Zipnol-Plus Tablet is a combination medication containing Clonazepam 0.25 mg and Propranolol 10 mg, formulated for the management of anxiety disorders, panic attacks, and certain cardiovascular conditions. Clonazepam, a benzodiazepine, exerts anxiolytic, anticonvulsant, and muscle relaxant effects by enhancing the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) activity in the central nervous system, thereby reducing neuronal excitability. Propranolol, a non-selective beta-adrenergic blocker, decreases heart rate, myocardial contractility, and blood pressure, effectively controlling symptoms such as tachycardia and tremors associated with anxiety and hypertension. The combined action of these agents provides both central nervous system calming and peripheral cardiovascular stabilization, making Zipnol-Plus suitable for patients experiencing anxiety with somatic manifestations or those requiring adjunctive therapy for hypertension with concurrent anxiety symptoms. It is important to use this medication under medical supervision due to potential side effects including drowsiness, dizziness, hypotension, bradycardia, and the risk of dependence associated with benzodiazepines. Caution is advised in patients with respiratory disorders, hepatic impairment, or cardiac conduction abnormalities. Dosage should be individualized based on clinical response, and abrupt discontinuation should be avoided to prevent withdrawal symptoms.